UT Health San Antonio leads effort for developing oral vaccine against chlamydia

FHS
May 9, 2024
6:16 pm

The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.

Power Secures $11.9M to Democratize Clinical Trials

What You Should Know: – Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round

February 22, 2024

Spexis Provides Update Regarding Debt-Restructuring Moratorium – Biotech Investments

Spexis AG / Key word(s): Miscellaneous 29-Nov-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

November 30, 2023

Natural Medicine Advisory Bulletin #6: November 2023 – Psychedelic Alpha

*** November’s meeting of the full Natural Medicine Advisory Board began with a brief administrative update from recently-appointed program director Lorey Bratten, mostly around new

December 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.